- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05580497
Soft Robotics for Infants With Cerebral Palsy
Soft Robotics for Improved Standing and Walking in Infants With Cerebral Palsy
Children with spastic cerebral palsy suffer from significant weakness that contributes to abnormal posture and movement. It is thought that this arises due lack of frequency sufficient tension to encourage normal muscular growth underlying the need for early intervention to encourage walking. The failure of muscle growth to keep pace with bone growth is most evident in the bi-articular muscles and contributes to joint contractures and gait abnormalities such as toe-walking and flexed-knee gait.
Recently, our research team has developed a novel, lightweight (0.2kg at knee joint) and portable (energetically autonomous) Soft Wearable Robotic Knee System that can provide active powered knee assistance and synchronized proprioceptive feedback for the gait training of stroke patients' standing and walking.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Shatin, Hong Kong
- Recruiting
- Department of Biomedical Engineering, The Chinese University of Hong Kong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- capable of understanding the proposed exercises;
- aged 2 to 15 years;
- maximum weight 75 kg;
- children with no deformations that could prevent the use of the exoskeleton;
- Gross Motor Function Classification System (GMFCS) levels I to III;
- able to signal pain or discomfort.
Exclusion Criteria:
- unhealed skin lesions in the lower limbs;
- aggressive or self-harming behaviors;
- severe cognitive impairment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Soft Wearable Robotic Knee System
30 minutes gait training wearing the Soft Wearable Robotic Knee System
|
Power assistance will be provided from the motor to the knee joint
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gross Motor Function Classification System
Time Frame: Within one month after the last training session
|
It categorized the gross motor function of children and young people with cerebral palsy into 5 different levels.
With level 1: Children walk at home, school, outdoors and in the community, while level 5: Children are transported in a manual wheelchair in all settings.
|
Within one month after the last training session
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-Minute-Walk Test
Time Frame: Within one month after the last training session
|
It is a sub-maximal exercise test used to assess aerobic capacity and endurance.
The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
|
Within one month after the last training session
|
|
10-Meter-Walk Test
Time Frame: Within one month after the last training session
|
It is a performance measure used to assess walking speed in meters per second over a short distance.
|
Within one month after the last training session
|
|
Timed Up and Go test
Time Frame: Within one month after the last training session
|
It is used to determine fall risk and measure the progress of balance, sit to stand and walking.
|
Within one month after the last training session
|
|
Five Times Sit to Stand Test
Time Frame: Within one month after the last training session
|
It is used to assess functional lower extremity strength, transitional movements, balance, and fall risk.
|
Within one month after the last training session
|
|
Berg Balance Scale
Time Frame: Within one month after the last training session
|
It is used to objectively determine a person's ability to safely balance during a series of predetermined tasks.
It is a 14-item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function.
|
Within one month after the last training session
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Raymond Tong, PhD, Department of Biomedical Engineering, The Chinese University of Hong Kong
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021.171
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.